Exicure ( (XCUR) ) has released a notification of late filing.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Exicure, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The primary reason for the delay is the additional time required to finalize financial statements, particularly due to technical accounting matters related to the acquisition of GPCR Therapeutics USA, Inc. This acquisition, which closed on January 19, 2025, has introduced complexities in the purchase price allocation that need to be resolved. Exicure anticipates filing the delayed report within the five-day grace period allowed by the SEC. The company has indicated that there will be significant changes in its financial results due to the acquisition, which will impact the comparability of the financial statements with the previous year’s corresponding period. Exicure is committed to maintaining compliance with regulatory requirements, as evidenced by the notification signed by CEO Andy Yoo.
Spark’s Take on XCUR Stock
According to Spark, TipRanks’ AI Analyst, XCUR is a Neutral.
Exicure’s overall stock score of 47.8 reflects significant financial challenges, including ongoing losses and reliance on external funding. Technical analysis indicates bearish momentum, and the valuation highlights risks due to negative profitability. The lack of earnings call and corporate events data further limits the assessment.
To see Spark’s full report on XCUR stock, click here.
More about Exicure
Average Trading Volume: 31,844
Technical Sentiment Signal: Hold
Current Market Cap: $72.02M
Learn more about XCUR stock on TipRanks’ Stock Analysis page.